EUVIMEDEUVIMED entdecken
Crossref

Suzetrigine (Journavx) for a Wide Range of Super‐refractory Chronic Pain Syndromes: A Case Series

Tianrun Pan, Jacob Hascalovici

PM&R · 2026-11 · 18 (S3)

DOI: 10.1002/pmrj.255_70259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Tianrun Pan und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

reflect greater axonal injury rather than an independent EDX marker of CRPS II.

Zitieren

APA

Pan, T., & Hascalovici, J. (2026). Suzetrigine (Journavx) for a Wide Range of Super‐refractory Chronic Pain Syndromes: A Case Series. PM&R, 18(S3). https://doi.org/10.1002/pmrj.255_70259

Vancouver

Pan T, Hascalovici J. Suzetrigine (Journavx) for a Wide Range of Super‐refractory Chronic Pain Syndromes: A Case Series. PM&R. 2026;18(S3). doi:10.1002/pmrj.255_70259

BibTeX
@article{Pan2026,
  author = {Pan, Tianrun and Hascalovici, Jacob},
  title = {Suzetrigine (Journavx) for a Wide Range of Super‐refractory Chronic Pain Syndromes: A Case Series},
  journal = {PM&R},
  year = {2026},
  volume = {18},
  number = {S3},
  doi = {10.1002/pmrj.255_70259}
}
Kostenlos starten →